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independence. Results: Smoothed rates of documentation of EF varied from 35-85% and 
of ACEI prescdption from 65-87% by HRR. Among 32,882 patients eligible for the EF QI, 
advanced age (OR 0.64, 95% CI 0.61-0.69), female gender (OR 0.87, 95% CI 0.82- 
0.92), low income (OR 0.77, 95% CI 0.73-0,82), hospital with invasive cardiac capabili- 
ties (OR 1.58, 95% CI 1.42-1.74), hospital with a medical school affiliation (OR 1.45, 95% 
CI 1.32-1.59), rural location (OR 0.50, 95% CI 0.45-0.56) and cardiologist as attending 
physician (OR 1.38, 95% CI 1.26-1.52) were independently associated with documenta- 
tion of El=. Among 9,368 patients eligible for the ACEI QI, female gender (OR 0.81, 95% 
CI 0.73-0.89), higher serum creatinine (OR 0.54, 95% CI 0.50-0.57), black race (OR 
1.34, 95% CI 1.13-1.59) and hospitalization at a teaching facility (OR 1.36, 95% CI 1.17- 
1.59) were independently associated with ACEI prescription. Conclusions: Patient, pro- 
vider and hospital characteristics contribute to but do not fully explain variation in quality 
of care for elderly heart failure patients. 
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849-4 Effectiveness of Quality Improvement Initiative 
(Guidelines Applied to Practice[GAP] Project) in 
Improving the Care of Medicare Patlente and Women 
With Acute Myocardial Infarction 
Raiendra H. Mehta, Cecelia K. Montoye, Meg Gallogly, Patricia Baker, Angela Blount, 
Staven Borzak, Eva Kline-Rogers, Thomas LaLonde, Michele Orza, Robert Parrish, 
Stuart Winston, Arthur A. Riba, Kim A. Eagle, On Behalf of GAP Investigators, University 
of Michigan Health System, Ann Arbor, Michigan. 
Background: Quality of care of patients with acute myocardial infarction (AMI) has been 
shown to be particularly suboptimal in the Medicare population and in females. Hence, 
improving care in this cohort prone to be deprived of key indicators for AMI care is of 
intense interest. 
Methods: To assess if a quality improvement initiative is effective in improving adher- 
ence to evidenca-based therapies in Medicare beneficiaries and women, we evaluated 
patients from the Guidelines Applied to Practice (GAP) project sponsored by the Ameri- 
can College of Cardiology. The GAP design consisted of baseline measurement, imple- 
mentation of improvement strategies (including among other components the use of tools 
designed to facilitate the adherence to key quality indicators); remeasurement; and com- 
parison of pre- and post samples. A random sample of Medicare and non-Medicare 
patients admitted for the treatment of confirmed AMI to 10 acute care hospitals in South- 
east Michigan at baseline (n=735) and following intervention (n=914) constituted the 
study population. 
Reeults: See table. # =test indicators, * = p < 0.05, pre =pre-intervention, post =post- 
intervention. 
Con¢luelons: The quality of care for Medicare beneficiaries and women with AMI was 
less optimal than for non-Medicare patients and men in the pre-GAP phase. A greater 
improvement was observed for most quality indicators for Medicare patients and women 
as oppose to non-Medicare patients and men, thereby ameliorating the 'GAP' in the care 
among these subgroups. 
Quality Indicators Non- Medicare Men Women 
Medicare 
Pre Post Pre Post Pre Post Pre Post 
N (%) 220 251 515 663 409 505 326 409 
(29.9) (27.5) (70.1) (72.5) (55.6) (55.3) (44.4) (44.7) 
Early aspirin % 90.6 88.0 76.6 87.1" 85.7 87.6 75.5 87.2* 
Early betablockers % 70.1 75.8 62.5 73.3* 71.4 73.4 55.0 75.5* 
Late aspirin % 86.8 92.8 82.0 91.7* 84.4 91.8* 83.0 92.6* 
Latebetablockers% 90.7 93.4 87.3 92.9 90.1 92.5 85.7 93.9* 
Discharge ACEinhibitors% 79.4 90.5 80.8 84.7 79.8 91.2* 80.0 78.9 
Smoking cessation % 70.2 79.7 27.7 50.4* 56.3 63.6 44.7 68.8* 
Early ACE inhibitors %# 35.0 42.2 33.7 43.7* 35.5 43.2 32.2 43.3* 
Diet counseling %# 75.5 80.0 61.7 65.5 70.8 73.2 60.3 65.7 
LDLassessment %# 72.2 75.8 58.4 67.1 66.2 67.2 61.1 72.3 
Cholasterol management %# 70.5 86.4 66.2 69.9 64.3 76.7 73.8 73.0 
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849-5 Strategies to Improve Guideline Adherence: A 
Randomized Clinical Trial 
Maria N. Ansari, Michael G. Shlipak, Paul A. Heidenreich, Barrv M. Massie. San 
Francisco VA Medical Center, San Francisco, California, UCSF, San Francisco, 
California. 
Background Clinical practice guidelines are designed to translate medical resaarch and 
expert opinion into recommendations for everyday practice; however their ability to affect 
clinician behavior has been limited. Objective To evaluate interventions for implementing 
a new practice guideline, which advocates beta-blockers (BBs) for patients (pts) with 
heart failure (HI=). Design and setting This study was a clinical trial that randomized pro- 
viders at the San Francisco VA Medical Center to one of 3 groups on 2/1/00: 1) Control: 
provider education (n= 25 providers, 61 pts); 2'~ Alert: computerized reminders to provid- 
ers and letters advocating BBs to pts (n=24 providers, 64 pts); and 3) Nurse Manaoe- 
ment: supervised nurse practitioner to initiate and titrate BBs with provider consent (n=25 
providers, 54 pts). The primary outcome was the proportion of pts identified as appropri- 
ate BB candidates who were initiated and maintained on BBs after 1 year of intervention 
or at the study endpoint on 4/16/01. Secondary outcomes included hospitalizations and 
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adverse events. Participant,= Inclusion criteria for pts were an ICD-9 HF diagnosis, 
EF_<45% and clinical evidence of HF. Exclusions included prior intolerance to BBs, BB 
use at target dose, lack of primary care at the VA, HR<60, SBP<90, severe COPD, 
asthma, diabetes with hypoglycamic events, and terminal comorbidities. Results Char- 
actedstics of providers (specialty, training level) and pts (age, EF, HF etiology, ocmorbidi- 
ties) were similar in the 3 intervention arms. Providers assigned to the Nurse 
Management arm initiated and maintained BBs in 61% of candidate pts compared with 
29% (p<.01) in the Control group and 12% (p<.001) in the Alert group. The Nurse Man- 
agement group also had the highest proportion of pts reaching target BB doses (43% vs. 
1.5% and 10%, p<0.001 for both) compared to the Alert and Control arms. There was no 
difference in adverse events (ER visits, hospitalizations, or deaths) during follow-up. 
Conclusions The use of a nurse manager was a successful and safe approach for 
implementing a BB guideline in HF pts. The use of provider education, clinical reminders, 
and patient education were of limited benefit in this setting. 
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849-6 Quality Improvement Over Time: Hospital 
Characteristics Associated With Increased Usage of 
Beta-Blockers After Myocardial Infarction 
Jennifer A. Mattera, Jeph Herrin, Elizabeth H. Bradley, Eric S. Holmboe, Paul Frederick, 
Hal V. Barren, Katherine A. Littrell, Nathan R. Every, Harlan M. Krumholz, Yale 
Universi~ New Haven, ConnecticuL 
Background: National organizations have focused on improving quality of care by 
increasing the use of beta-blockers (BB) at hospital discharge after acute myocardial inf- 
arction (AMI). Little is known about the factors associated with hospital performance 
improvement. Our objective was to determine the hospital characteristics independently 
associated with increasing the use of BB over time. 
Methods: We examined data on 325,510 discharges at 665 hospitals in the United States 
collected for the National Registry of Myocardial Infarction from 1996 to 1999. Using 
logistic hierarchical modeling techniques we examined the hospital-level characteristics 
associated with increasing use of BB after AMI over a time period. The likelihood of use 
of BB was adjusted at the patient level for age, gender, ethnicity, comorbidities, and 
insurance. Change in hospital rate over time was then modeled as a function of hospital 
ownership, teaching status, urbanity, annual AMI volume, catheterization lab status, and 
the baseline rate. 
Results: We observed marked variability in the change in BB use over time at the hospi- 
tals with an absolute mean improvement of 8% (standard deviation (SD) 10.2%). After 
adjusting for patient characteristics and baseline rate, urban teaching hospitals 
(P=0.003) and higher volume (P=0.017) were found to be significantly associated with 
increased use of BB over time. Hospital ownership and catheterization lab status were 
not independently associated with change over time. 
Conclusion: Hospitals increased use of BB during the study period at different rates. We 
identified hospital ocation and volume as independent markers of larger increases in the 
use of BB. The heterogeneity in performance by hospital type may provide an opportunity 
to investigate successful strategies to accelerate improvement. 
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1168-163 Racial and Gender Differences in Refusal of Coronary 
Angiography 
Paul Heidenreich, Michael Shlipak, Jeffrey Geppert, Mark McClellan, VA Palo Alto Health 
Care System, Palo Alto, Califomia. 
Background. Racial and gender differences in the use of cardiovascular procedures are 
well documented. It is unclear to what extent patient refusal contributas to the difference 
in procedure use. Methods. To determine the effect of patient refusal on racial and gen- 
der differences in coronary angiography utilization we identified patients of age 65 or 
older admitted to hospitals performing coronary angiography from the Cooperative Car- 
diovascular Project Database, which includes nearly all Medicare beneficiaries admitted 
with an acute myocardial infarction (MI) from February 1994 through July 1995. In-hospi- 
tal use and refusal of coronary angiography adjusted for patient comorbidities, severity of 
infarction, hospital, physician, and socio-economic status. 
Results. Of 124,691 patients with acute MI 53,871 (43%) patients underwent angiogre- 
phy and 2,881 (2.4%) patients refused during hospitalization. Patients refusing angiogra- 
phy were more likely to be female (odds ratio 1.37, 95% confidence interval 1.23 - 1.53), 
black (odds ratio 1.26 versus whites, 1.02-1.56) and older (odds ratio 2.25 per 10 year 
increase, 2.05-2.43) when compared to patients that received angiogrephy. Angiography 
use was lower for blacks (odds ratio 0.78, 0.72-0.83) compared with whites, and for 
women (odds ratio 0.83, 0.80-0.86) compared with men. Increased refusal explained 6% 
(-3% to 15%) of the difference in angiography use between whites and blacks and 16% 
(10% to 22%) of the difference between males and females. Patients who refused were 
twice as likely to die during the year following MI (31% vs. 16%), but this mortality differ- 
ence disappeared after adjustment for patient-relatad variables. 
Conclusions. Elderly females and black patients are more likely to refuse angiography 
than are male and white patients. However, patient refusal is relatively uncommon and 
accounts for only a small fraction of the racial and gender differences in angiography uti- 
lization after MI. 
